Table of Contents Table of Contents
Previous Page  523 / 1068 Next Page
Information
Show Menu
Previous Page 523 / 1068 Next Page
Page Background

Hyperfractionation

RTOG 00-12

hyperfractionated CRT did not improve

the rate of pathologic complete response

or any clinical outcome (LC, DFS, OS)

Mohiuddin M,

et al.

Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase

2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer. Int J Radiat Oncol Biol Phys 2013:

86:523–528